Perjeta
FDA approves breakthrough breast cancer drug
- Mon, 06/11/2012 - 2:57pm
In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.